Vigil Neuroscience, Inc., (VIGL): Price and Financial Metrics Recent IPO


Vigil Neuroscience, Inc., (VIGL): $2.83

0.05 (+1.80%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add VIGL to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

VIGL Stock Price Chart Interactive Chart >

Price chart for VIGL

VIGL Price/Volume Stats

Current price $2.83 52-week high $18.27
Prev. close $2.78 52-week low $2.18
Day low $2.64 Volume 49,607
Day high $3.12 Avg. volume 91,295
50-day MA $3.34 Dividend yield N/A
200-day MA $0.00 Market Cap 80.00M

Vigil Neuroscience, Inc., (VIGL) Company Bio


Vigil Neuroscience, Inc., a biotechnology company, discovers and develops novel therapeutics that take advantage of breakthroughs in science and human genetics of microglia. It harnesses the power of microglia for the treatment of neurodegenerative diseases by restoring the vigilance of microglia, the sentinel cells of the brain's immune system. The company was incorporated in 2020 and is based in Cambridge, Massachusetts.


VIGL Latest News Stream


Event/Time News Detail
Loading, please wait...

VIGL Latest Social Stream


Loading social stream, please wait...

View Full VIGL Social Stream

Latest VIGL News From Around the Web

Below are the latest news stories about Vigil Neuroscience Inc that investors may wish to consider to help them evaluate VIGL as an investment opportunity.

Wall Street gyrations may thwart deal closings, IPO outlook

In terms of doing mergers and acquisitions and raising money through initial public offerings, 2021 was huge. But 2022 may be vastly different.

Yahoo | January 27, 2022

New Year, Fresh Stocks: 3 IPOs That Joined the Market in January

Whether you're new to the stock market or have been investing for years, initial public offerings (IPOs) can be exciting. An IPO happens when a company begins offering shares of stock for the first time. Could any of these three IPOs be a good fit for your portfolio?

Yahoo | January 27, 2022

Newly listed Amylyx, Vigil Neurosciences and CinCor rebound after falling below IPO prices

Amylyx Pharmaceuticals, Vigil Neurosciences and CinCor Pharma all gained ground Tuesday after falling below their IPO prices on Monday.

Seeking Alpha | January 11, 2022

Vigil Neuroscience Announces Closing of Initial Public Offering

CAMBRIDGE, Mass., Jan. 11, 2022 (GLOBE NEWSWIRE) -- Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of neurodegenerative diseases, today announced the closing of its initial public offering of 7,000,000 shares of its common stock at a price to the public of $14.00 per share. The gross proceeds of the offering were $98 million, before deducting underwriting discounts and commissions and other offering

Yahoo | January 11, 2022

Vigil Neuroscience Announces Pricing of Initial Public Offering

CAMBRIDGE, Mass., Jan. 06, 2022 (GLOBE NEWSWIRE) -- Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of neurodegenerative diseases, today announced the pricing of its initial public offering of 7,000,000 shares of its common stock at a price to the public of $14.00 per share. All of the shares are being offered by Vigil Neuroscience. The gross proceeds of the offering, before deducting underwriting di

Yahoo | January 7, 2022

Read More 'VIGL' Stories Here

VIGL Price Returns

1-mo N/A
3-mo -59.74%
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
YTD N/A
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.468 seconds.